Clinical Trials Directory

Trials / Completed

CompletedNCT03926962

The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 4873 In Healthy Adult Volunteers

Double-Blind, Randomized, Placebo-Controlled Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 4873 In Healthy Adult Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
67 (actual)
Sponsor
Wockhardt · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This is a double-blind, randomized, placebo-controlled study, consisting of a single ascending dose (SAD) part and a 2-way crossover food effect (FE) part. Each subject will participate in only one cohort during the study.

Conditions

Interventions

TypeNameDescription
DRUGWCK 4873100 to 1200 mg in tablets (the 100 mg dose cohort will receive half a tablet; higher dose cohorts will receive 1 or more tablets)
DRUGPlacebo Oral TabletVisually matching placebo

Timeline

Start date
2013-03-14
Primary completion
2013-06-25
Completion
2013-07-13
First posted
2019-04-25
Last updated
2019-04-25

Source: ClinicalTrials.gov record NCT03926962. Inclusion in this directory is not an endorsement.

The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 4873 In Healt (NCT03926962) · Clinical Trials Directory